NCT01442168 - Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

January 31, 2014

Conditions

Malaria, Falciparum

Interventions

DRUG

Sevuparin sodium + atovaquone/proquanil

Sevuparin 4 times per day and malanil according to label

DRUG

atovaquone/proquanil

malanil according to label

Trial Locations (3)

Mae Ramat Hospital, Mae Ramat

Maesot General hospital, Mae Sot

Hospital for Tropical Diseases, Bangkok